China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Construction of a platform for evaluating eficacy and safety of drugs for cardiovascular-kidney-metabolic syndrome'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135597
Registration Time: 2026/10/30
Type: Observational study
Primary Sponsor: Peking University Third Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=349865
Published by HT Digital Content Services with permission from Health Daily Digest....